Covert pharmaceutical promotion in free medical journals
AS Kesselheim - CMAJ, 2011 - Can Med Assoc
The influence of the promotional prac-tices of pharmaceutical manufacturers on the
prescribing behaviour of physicians has long been recognized. Since the early 1980s …
prescribing behaviour of physicians has long been recognized. Since the early 1980s …
Drug advertisements: what a physician should know
Drug promotions and marketing initiatives by pharmaceutical companies have a substantial
impact on the prescribing pattern of physicians in terms of non rational prescribing …
impact on the prescribing pattern of physicians in terms of non rational prescribing …
[HTML][HTML] Policing the promotion of prescription medicines–the new Medicines Australia Code of Conduct
B Mintzes - Australian Prescriber, 2021 - ncbi.nlm.nih.gov
Promotion is ubiquitous in clinical practice. Industry funds most medical research and much
continuing medical education. Many clinical experts are paid by the industry to be 'key …
continuing medical education. Many clinical experts are paid by the industry to be 'key …
CMA calls for controls on prescription-drug advertising aimed at patients
P Sullivan - CMAJ: Canadian Medical Association Journal, 1996 - ncbi.nlm.nih.gov
Abstract The CMA Board of Directors has responded to growing physician concern about
prescription-drug advertising aimed at patients by issuing a position paper that calls for strict …
prescription-drug advertising aimed at patients by issuing a position paper that calls for strict …
Report calls for end of drug promotion to doctors
B Roehr - BMJ: British Medical Journal (Online), 2009 - search.proquest.com
Report calls for end of drug promotion to doctors Report calls for end of drug promotion to doctors
Abstract Product promotion among doctors by drug companies and medical device …
Abstract Product promotion among doctors by drug companies and medical device …
Pharmaceutical industry off-label promotion and self-regulation: a document analysis of off-label promotion rulings by the United Kingdom prescription medicines code …
A Vilhelmsson, C Davis, S Mulinari - PLoS medicine, 2016 - journals.plos.org
Background European Union law prohibits companies from marketing drugs off-label. In the
United Kingdom—as in some other European countries, but unlike the United States …
United Kingdom—as in some other European countries, but unlike the United States …
Better the devil you know than the doctor you don't: is advertising drugs to doctors more harmful than advertising to patients?
R Vaithianathan - Journal of Health Services Research & …, 2006 - journals.sagepub.com
Most countries ban the advertising of prescription medication directly to consumers, yet
allow drug companies to promote drugs to doctors intensively. Such a differential treatment …
allow drug companies to promote drugs to doctors intensively. Such a differential treatment …
Stop advertising
J Cave - Drug and Therapeutics Bulletin, 2022 - dtb.bmj.com
James cave, Editor-in-Chief The Downland Practice, Berkshire, UK correspondence to
jcave@ bmj. com in the uK, the promotion and advertising of prescription-only medicines …
jcave@ bmj. com in the uK, the promotion and advertising of prescription-only medicines …
[HTML][HTML] Direct-to-consumer information in Europe: the blurred margin between promotion and information
G Velo, U Moretti - British journal of clinical pharmacology, 2008 - ncbi.nlm.nih.gov
During the last year, many papers in scientific journals have commented on the possible
removal of the ban on directto-consumer advertising (DTCA) of prescription drugs by the …
removal of the ban on directto-consumer advertising (DTCA) of prescription drugs by the …
Medicines information and the regulation of the promotion of pharmaceuticals
Many factors contribute to the inappropriate use of medicines, including not only a lack of
information but also inaccurate and misleading promotional information. This review …
information but also inaccurate and misleading promotional information. This review …